An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, offering a new treatment option for cardiovascular protection. Sotagliflozin, a re ...

Pulmonary Artery Pressure Monitoring Falls Short, New Diuretic Insights Emerge Oak Ridge, TN, Feb. 19, 2025 (GLOBE NEWSWIRE) ...

the MBA/MPH for public health professionals, and the MBA in combination with our surgical residency, for surgeons-in-training. Contact the School of Management for more information about these ...

A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

Tofu is a versatile plant-based food that can replace eggs in scrambles, egg sandwiches, and many other breakfast dishes.

Dr. Tom Walsh, DVM, CCRP, MBA talks with Adam Christman, DVM, MBA, about how a change in career sparked a mobile physical ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Tom Werner / Getty Images For many people, the deciding factor between picking a standard, full-time MBA vs. a part-time executive MBA (EMBA) comes down to how best to juggle classes with the ...

Sotagliflozin, recently approved by the FDA for treating type 2 diabetes and kidney disease in patients with cardiovascular ...

While conducting the study, the researchers tracked data from more than 10,000 patients who presented with type 2 diabetes, ...